COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 197 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $886 | +21.7% | 39,593 | +16.9% | 0.00% | – |
Q2 2023 | $728 | -12.4% | 33,880 | -2.2% | 0.00% | – |
Q1 2023 | $831 | +18.5% | 34,649 | +14.6% | 0.00% | – |
Q4 2022 | $701 | -99.8% | 30,222 | +14.8% | 0.00% | – |
Q3 2022 | $423,000 | -42.2% | 26,336 | -36.3% | 0.00% | – |
Q2 2022 | $732,000 | -26.7% | 41,343 | -15.7% | 0.00% | -100.0% |
Q1 2022 | $998,000 | -63.2% | 49,026 | -66.2% | 0.00% | 0.0% |
Q4 2021 | $2,712,000 | +63.2% | 145,182 | +72.5% | 0.00% | 0.0% |
Q3 2021 | $1,662,000 | +39.5% | 84,160 | +66.9% | 0.00% | 0.0% |
Q2 2021 | $1,191,000 | -31.7% | 50,413 | -31.5% | 0.00% | 0.0% |
Q1 2021 | $1,745,000 | +675.6% | 73,642 | +554.7% | 0.00% | – |
Q4 2020 | $225,000 | -31.4% | 11,248 | -28.8% | 0.00% | – |
Q3 2020 | $328,000 | -0.9% | 15,795 | -16.6% | 0.00% | – |
Q2 2020 | $331,000 | +86.0% | 18,932 | +74.1% | 0.00% | – |
Q1 2020 | $178,000 | -73.1% | 10,877 | -66.2% | 0.00% | – |
Q4 2019 | $662,000 | +136.4% | 32,161 | +31.8% | 0.00% | – |
Q3 2019 | $280,000 | -4.4% | 24,408 | +9.5% | 0.00% | – |
Q2 2019 | $293,000 | -62.7% | 22,300 | -57.0% | 0.00% | -100.0% |
Q1 2019 | $786,000 | -2.1% | 51,857 | +11.0% | 0.00% | 0.0% |
Q4 2018 | $803,000 | -63.5% | 46,707 | -68.7% | 0.00% | 0.0% |
Q3 2018 | $2,202,000 | +1368.0% | 149,419 | +2268.0% | 0.00% | – |
Q2 2018 | $150,000 | -45.7% | 6,310 | -41.3% | 0.00% | – |
Q1 2018 | $276,000 | +196.8% | 10,757 | +113.3% | 0.00% | – |
Q4 2017 | $93,000 | +1450.0% | 5,044 | +858.9% | 0.00% | – |
Q3 2017 | $6,000 | +100.0% | 526 | +123.8% | 0.00% | – |
Q2 2017 | $3,000 | -95.2% | 235 | -96.1% | 0.00% | – |
Q1 2017 | $62,000 | -93.5% | 6,091 | -90.1% | 0.00% | -100.0% |
Q4 2016 | $959,000 | -11.6% | 61,607 | +9.4% | 0.00% | 0.0% |
Q3 2016 | $1,085,000 | +27025.0% | 56,308 | +17832.5% | 0.00% | – |
Q2 2016 | $4,000 | +100.0% | 314 | +175.4% | 0.00% | – |
Q1 2016 | $2,000 | -77.8% | 114 | -64.8% | 0.00% | – |
Q4 2015 | $9,000 | +800.0% | 324 | +825.7% | 0.00% | – |
Q3 2015 | $1,000 | -50.0% | 35 | -72.7% | 0.00% | – |
Q2 2015 | $2,000 | – | 128 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |